FDA approves ARS Pharma’s nasal spray to treat dangerous allergic reactions
“We don’t want fear. There’s no needle, there’s no pain with this product,” he said. “It’s basically like spraying saline ...
pharmaphorum3d
FDA declines to approve needle-free epinephrine from ARS
Shares in ARS Pharmaceuticals were in freefall in pre ... aiming to become the first needle-free epinephrine product to treat severe allergic reactions. The nasal spray, dubbed neffy, has been ...
Nasdaq11d
ARS Pharmaceuticals Announces FDA Approval of neffy® 1 mg, First Needle-Free Epinephrine Treatment for Children Ages 4 and Up
neffy 1 mg is the first approved needle-free epinephrine nasal spray for children aged 4 to 30 kg, addressing severe allergic reactions. ARS Pharmaceuticals announced the FDA approval of neffy 1 ...